Associated Papers
Molecular Determinants of Sensitivity to Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma.
Corcoran SR et al.
Cancer Discovery, 2024
MYD88, CD79B, and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma.
Takeuchi T et al.
Cancer, 2017
Targetable activating mutations are very frequent in GCB and ABC diffuse large B-cell lymphoma.
Bohers E et al.
Genes, Chromosomes & Cancer, 2014
Select a paper to view details